Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males

Background Susceptibility to viral infections as well as their severity are higher in men than in women. Heightened antiviral responses typical of women are effective for rapid virus clearance, but if excessively high or prolonged, can result in chronic/inflammatory pathologies. We investigated whether this variability could be in part attributable to differences in the response to the Toll-Like Receptors (TLR) more involved in the virus recognition. Methods Cytokine production by peripheral blood mononuclear cells (PBMCs) from male and female healthy donors after stimulation with Toll-like receptors (TLR) 3, 7, 8, 9 ligands or with viruses (influenza and Herpes-simplex-1) was evaluated. Results Compared to females, PBMCs from males produced not only lower amounts of IFN-α in response to TLR7 ligands but also higher amounts of the immunosuppressive cytokine IL10 after stimulation with TLR8 and TLR9 ligands or viruses. IL10 production after TLR9 ligands or HSV-1 stimulation was significantly related with plasma levels of sex hormones in both groups, whereas no correlation was found in cytokines produced following TLR7 and TLR8 stimulation. Conclusions Given the role of an early production of IL10 by cells of innate immunity in modulating innate and adaptive immune response to viruses, we suggest that sex-related difference in its production following viral nucleic acid stimulation of TLRs may be involved in the sex-related variability in response to viral infections.

[1]  M. Stepanova,et al.  Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity , 2012, Journal of viral hepatitis.

[2]  D. Ye,et al.  Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study , 2012, BMC Public Health.

[3]  H. Heinzl,et al.  Association of age and gender with alphaherpesvirus infections of the central nervous system in the immunocompetent host. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  S. Klein,et al.  Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice. , 2011, Vaccine.

[5]  D. Chaussabel,et al.  Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity , 2011, The Journal of experimental medicine.

[6]  W. Choi,et al.  Male predominance of pneumonia and hospitalization in pandemic influenza A (H1N1) 2009 infection , 2011, BMC Research Notes.

[7]  R. Catarino,et al.  Epstein-Barr virus in healthy individuals from Portugal. , 2011, Acta medica portuguesa.

[8]  S. Klein,et al.  Elevated 17β-Estradiol Protects Females from Influenza A Virus Pathogenesis by Suppressing Inflammatory Responses , 2011, PLoS pathogens.

[9]  E. McClelland,et al.  Gender Specific Differences in the Immune Response to Infection , 2011, Archivum Immunologiae et Therapiae Experimentalis.

[10]  R. Booy,et al.  Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009 , 2011, Influenza and other respiratory viruses.

[11]  K. Heeg,et al.  PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3 , 2011, European journal of immunology.

[12]  Takeshi Ichinohe,et al.  Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design , 2010, Expert review of vaccines.

[13]  R. P. Arya,et al.  Role of Host Immune Response and Viral Load in the Differential Outcome of Pandemic H1N1 (2009) Influenza Virus Infection in Indian Patients , 2010, PloS one.

[14]  M. Montero‐Odasso,et al.  LOWER MORTALITY FROM H1N1 INFLUENZA IN OLDER ARGENTINEANS: MEN MORE AFFECTED , 2010, Journal of the American Geriatrics Society.

[15]  C. Libert,et al.  The X chromosome in immune functions: when a chromosome makes the difference , 2010, Nature Reviews Immunology.

[16]  Z. Chang.  Important aspects of Toll-like receptors, ligands and their signaling pathways , 2010, Inflammation Research.

[17]  A. Kamen,et al.  Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. , 2010, Vaccine.

[18]  Andrew Pekosz,et al.  The Xs and Y of immune responses to viral vaccines. , 2010, The Lancet. Infectious diseases.

[19]  N. Khan,et al.  Effects of age, gender, and immunosuppressive agents on in vivo toll-like receptor pathway responses. , 2010, Human immunology.

[20]  Y. Leo,et al.  Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  C. Coban,et al.  Plasmacytoid Dendritic Cells Delineate Immunogenicity of Influenza Vaccine Subtypes , 2010, Science Translational Medicine.

[22]  D. Metzger,et al.  A Detrimental Effect of Interleukin-10 on Protective Pulmonary Humoral Immunity during Primary Influenza A Virus Infection , 2010, Journal of Virology.

[23]  Q. Ou,et al.  Hospitalized patients with novel influenza A (H1N1) virus infection: Shanghai, June - July 2009. , 2010, Chinese medical journal.

[24]  Bin Cao,et al.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. , 2009, The New England journal of medicine.

[25]  M. Altfeld,et al.  Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 , 2009, Nature Medicine.

[26]  M. Pallardy,et al.  TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation , 2009, Journal of leukocyte biology.

[27]  G. Freeman,et al.  IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection , 2008, Proceedings of the National Academy of Sciences.

[28]  Shizuo Akira,et al.  Toll‐like Receptor and RIG‐1‐like Receptor Signaling , 2008, Annals of the New York Academy of Sciences.

[29]  A. Jukkola-Vuorinen,et al.  Toll-Like Receptor-9 Expression Is Inversely Correlated with Estrogen Receptor Status in Breast Cancer , 2008, Journal of Innate Immunity.

[30]  Jeremy H. Herskowitz,et al.  The MHV68 M2 Protein Drives IL-10 Dependent B Cell Proliferation and Differentiation , 2008, PLoS pathogens.

[31]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[32]  K. Jerome,et al.  Herpes Simplex Virus Remodels T-Cell Receptor Signaling, Resulting in p38-Dependent Selective Synthesis of Interleukin-10 , 2007, Journal of Virology.

[33]  G. Barton.  Viral recognition by Toll-like receptors. , 2007, Seminars in immunology.

[34]  H. Hackstein,et al.  TLR7 Ligands Induce Higher IFN-α Production in Females1 , 2006, The Journal of Immunology.

[35]  D. Celentano,et al.  Gender differences in the prevalence of sexually transmitted infections and genital symptoms in an urban setting in southern India , 2006, Sexually Transmitted Infections.

[36]  M. Colonna,et al.  Dendritic cells respond to influenza virus through TLR7‐ and PKR‐independent pathways , 2005, European journal of immunology.

[37]  F. Schmitz,et al.  Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways , 2004 .

[38]  M. Heineman,et al.  Gender Difference in the Non‐Specific and Specific Immune Response in Humans , 2004, American journal of reproductive immunology.

[39]  M. Imawari,et al.  Hepatitis B core antigen stimulates interleukin‐10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection , 2004, Clinical and experimental immunology.

[40]  W. Reeves,et al.  Epidemiology of recurrent genital herpes simplex virus types 1 and 2 , 2003, Sexually transmitted infections.

[41]  K. Mills,et al.  Hepatitis C virus non‐structural protein 4 suppresses Th1 responses by stimulating IL‐10 production from monocytes , 2003, European journal of immunology.

[42]  S. Akira,et al.  Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.

[43]  J. Katz,et al.  Cutting Edge: Impaired Toll-Like Receptor Expression and Function in Aging , 2002, The Journal of Immunology.

[44]  K. Mills,et al.  Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.

[45]  R. Voskuhl,et al.  Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production1 , 2001, The Journal of Immunology.

[46]  T. Sugie,et al.  Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Lundberg,et al.  Gender Influences Herpes Simplex Virus Type 1 Infection in Normal and Gamma Interferon-Mutant Mice , 2001, Journal of Virology.

[48]  T. F. Smith,et al.  Replication and plaque assay of influenza virus in an established line of canine kidney cells. , 1968, Applied microbiology.

[49]  A. Schmidt,et al.  Sensing of viral nucleic acids by RIG-I: from translocation to translation. , 2012, European journal of cell biology.

[50]  H. Hackstein,et al.  TLR7 ligands induce higher IFN-alpha production in females. , 2006, Journal of immunology.

[51]  F. Schmitz,et al.  Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.